Invicta Diagnostic Limited IPO
Invicta Diagnostic Limited IPO
Invicta Diagnostic Limited IPO
₹ 272000 / 3200 Shares Shares
Minimum Investment
Invicta Diagnostic Limited IPO
Issues Price
₹80-85 per equity share
Invicta Diagnostic Limited IPO
Open Date
01 Dec 2025
Close Date
03 Dec 2025
Lot Size
1600
Min. Investment
₹ 272000
Issue Price
₹80-85
Listing Date
08 Dec 2025
Issues Size
33,08,800 shares(aggregating up to ₹28.12 crore)
Face Value
₹10 Per Equity Share
Total Shares Offered
3200 Shares
Offered To Public
3200 Shares
Invicta Diagnostic Limited IPO
Incorporated in January 2021, Invicta Diagnostic Limited offers radiology and pathology solutions. It provides pathology and radiology testing comprising imaging, radiology, pathology, and teleradiology services under the brand 'PC Diagnostics” through 7 diagnostic centres and a central laboratory across Mumbai in Maharashtra. Invicta Diagnostics Limited, trading as PC Diagnostics, is a Mumbai-based diagnostic services company specializing in integrated pathology and radiology solutions. The company follows a hub‑and‑spoke model across the Mumbai Metropolitan Region, featuring: A flagship hub offering full-spectrum pathology and advanced radiology (CT, MRI) at Thane West Three other centres - Bhayandar, Byculla, Marol - offering specialized diagnostic services Basic imaging, including X-ray and ultrasound, and sample collection were the focus of spokes at Lower Parel, Sewri, Mazgaon, and Kalwa. It offers approximately 60 routine and 487 specialized pathology tests and around 96 basic and 130 advanced radiology investigations. Invicta Diagnostics provides a comprehensive suite of diagnostic services that includes: Routine Tests: Includes CBC, lipid profiles, liver function tests (LFT), kidney function tests (KFT), and thyroid panels Specialized Tests: Molecular diagnostics, immunoassays, infectious disease markers including dengue, COVID-19, cancer markers, and genetic panels. Sample Collection Network: Invicta uses phlebotomists and collection partners to reach patients at home or through its spoke centres. The company has a network of 5 laboratory doctors, 20 radiologists, and 127 well-trained technical staff as of May 31st, 2025. The company has 105 permanent employees as of May 31, 2025.
Founded In
2021
Managing Director
Dr. Ketan Jayantilal Jain
Parent Organization
Invicta Diagnostic Limited IPO
Application for Invicta Diagnostic Limited IPO
| Apply as | Price Range | Apply Upto |
|---|---|---|
| Individual (min) | ₹80-85 | ₹2,72,000 |
| Individual(max) | ₹80-85 | ₹2,72,000 |
| SHNI(min) | ₹80-85 | ₹4,08,000 |
| SHNI(max) | ₹80-85 | ₹9,52,000 |
| BHNI(min) | ₹80-85 | ₹10,88,000 |
Apply for all eligible candidates, Invicta Diagnostic Limited IPO.
Open On12 Dec 2025
Close On16 Dec 2025
Price Range₹2061-2165
Testimonial
Genuine Review Form Statisifed Customers
Mutual funds were new to me, but KSquare’s team made sure I understood everything. I now invest regularly with confidence and clarity.
I used KSquare to meet some short-term needs, and their loan against mutual funds service was quick and easy.
KSquare helped me choose the right pension fund with detailed comparisons. Their expert team made everything clear.
KSquare’s NRI Corner was a game-changer for managing my Indian assets. Their process is smooth, transparent, and perfectly suited for NRIs like me.
KSquare’s SIP plans make long-term investing easier than ever. I set up my account in minutes and now watch my portfolio grow every month.
Thanks to KSquare, I’ve finally started saving regularly. Their SIP structure fits my needs, and I feel much more confident about my financial future.
I feel empowered thanks to KSquare. Their NRI Corner is well-structured, and the financial advice is incredibly relevant and actionable.
I was looking for a secure retirement plan, and KSquare’s NPS guidance made it very easy to start.
KSquare really simplified the NPS process for me. I appreciate their educational approach and helpful customer support.
KSquare gave me clarity in my mutual fund journey. I now know where my money goes and how it grows. Their dashboard is excellent.
FAQ's
Frequenlty Asked Question
What documents are needed to invest in an NFO through KSquare?
You’ll need KYC-compliant documents like PAN, Aadhaar, and bank details to invest in NFOs through KSquare.
Is there a processing fee for LAMF through KSquare?
A nominal processing fee may apply depending on the lender. KSquare clearly discloses all charges upfront.
Is NPS better than PPF or EPF for retirement?
NPS can offer higher returns due to market exposure, while PPF and EPF are safer but lower-yielding. It’s best to diversify.
How does KSquare ensure compliance with FEMA rules?
KSquare’s advisory follows all FEMA guidelines, helping NRIs invest safely while staying compliant with Indian regulations.
Do I need a demat account to apply for this loan?
Yes, most lenders require mutual fund units in demat form. KSquare can help convert physical units if needed.
Can I invest jointly with a resident Indian through KSquare?
Yes, joint investments are allowed with a resident Indian, provided KYC and bank account norms are met.
Can I use LAMF for personal or business purposes?
Yes, the loan can be used for any legal personal or business need such as emergencies, education, or working capital.
What documents are needed for applying LAMF?
Basic KYC documents, bank statements, and demat account details are required. KSquare helps with digital submission.
Ksquare Timeline Pvt. Ltd. is an AMFI Registered Mutual Fund Distributor having ARN No. 146262. Mutual Fund investments are subject to market risks. Please read all scheme related documents carefully before investing. This website is intended only for informational and self-help purposes and should not be considered as investment advice or return guarantee. Past performance is not indicative of future results. Terms & Conditions apply.